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Abstract
With the advent of whole genome screens, promoter-proximal pausing of RNA polymerase II (RNAPII) has
been shown to play a much more significant role in eukaryotic systems than previously thought. This type of
transcription inhibition is dependent on the binding of the Negative Elongation Factor (NELF) complex which
is composed of four sub-units, presenting unique domains and consequently fulfilling different functions.
Numerous questions still surround the mechanism by which NELF is recruited, stabilised and dissociated
from the RNAPII complex. Furthermore, not much is known about which other transcription stages the
NELF complex is involved in and through which sub-units it carries out such functions. Based on the current
knowledge of the role of NELF in transcription pausing, it is hypothesised that different interaction partners
are required to direct context-specific functions of the NELF complex. This review covers some of the known
roles and contexts in which NELF acts in an attempt to identify key questions for future NELF-dependent
transcriptional research.
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1 .The Negative Elongation Factor (NELF) is a multi-
subunit transcription elongation factor
2 .The great majority of human protein coding
genes exhibit promoter-proximal pausing of RNA
Polymerase II (RNAPII) as a result of NELF action
3 .NELF can only bind to a pre-formed 5,6-Dichloro-1-
β-D-ribofuranosylbenzimidazole (DRB) Sensitivity-
Inducing Factor (DSIF)/RNAPII complex
4 .NELF is involved in multiple mRNA processing
steps during transcription by interacting with
different factors
5 .Transcription factors e.g. GAGA factor can recruit
proteins involved in promoter-proximal pausing of
RNAPII
The NELF complex
The Negative Elongation Factor (NELF) complex,
originally isolated through its suppression of
transcription elongation, is a multi-subunit
transcription elongation factor composed of four
sub-units: NELF-A (66kDa), NELF-B (62kDa), NELF-C
(60kDa) or NELF-D (59kDa), and NELF-E (46kDa) [1-4].
NELF induces a process called promoter-proximal
pausing of RNA polymerase II (RNAPII) [5-7].
NELF-A is encoded by the WHSC2 gene, a
candidate gene for Wolf-Hirschhorn syndrome –
characterised by a distinctive craniofacial phenotype,
growth and mental retardation, seizures and cardiac
abnormalities [3,8-10]. Interestingly, the N-terminal
segment of NELF-A shows sequence similarity to the
hepatitis delta antigen (HDAg), which binds to RNAPII
and activates transcription elongation, indicating
that NELF-A mediates the interaction between NELF
and RNAPII [3,7].
NELF-B (also known as cofactor of BRCA1 –
COBRA) has been reported to physically interact with
the product of breast/ovarian cancer susceptibility
gene, BRCA1 and computer analysis has shown
that this interaction occurs between a coiled-coil
structure in NELF-B and a leucine zipper motif in
NELF-E [1,11]. It has been shown that NELF-B inhibits
the growth of oestrogen receptor α (ERα) positive
breast cancer cells in vitro [12] and that NELF-B
expression is reduced in several established breast
cancer cell lines [13]. A study of a cohort of breast
ductal carcinoma samples from patients with known
clinical outcomes revealed that a low level of NELF-
B mRNA is associated with metastatic breast cancer
[14]. In a different context, mice homozygous for a
mutation in NELF-B have an inner cell mass deficiency
and die at the time of implantation, providing
evidence as to the critical role of NELF-B in early
mouse embryogenesis [15].
NELF-C and NELF-D are the least studied of
the NELF sub-units. It is known that they arise
from a common mRNA species through the use of
alternative start codons [1] and that they are highly
similar in sequence to the Drosophila protein TH1,
which as yet has no known function. However no
2other functional information has been reported in
the literature.
The structure of NELF-E is characterised by an
N-terminal leucine zipper motif, a central domain
rich in arginine and aspartic acid (Arg-Asp or R-
D) dipeptide repeats (the RD motif), and a C-
terminal RNA recognition motif (RRM). RRMs, which
typically encompass 80 to 90 amino acids with two
highly conserved elements called RNP1 and RNP2,
often bind to RNA in a sequence- or structure-
specific manner [16,17]. The RRM of NELF-E is
capable of binding to various nascent RNA transcripts
synthesised by RNAPII, and in so doing, repressing
transcription [4].
Promoter-Proximal Pausing
In yeast, RNAPII is typically distributed roughly
uniformly across transcription units, suggesting a
context in which RNAPII is not regulated after
transcription is initiated [18]. However, in higher
eukaryotes, RNAPII-binding is concentrated near the
Transcription Start Site (TSS) of many genes, implying
the action of a control process referred to as
promoter-proximal pausing.
Promoter-proximal pausing of RNAPII is a
mechanism that finely controls the levels of
gene expression, as opposed to, switching gene
expression on and off. This is brought about
by the physically binding of 5,6-Dichloro-1-
β-D-ribofuranosylbenzimidazole  (DRB) Sensitivity-
Inducing Factor (DSIF) to RNAPII, without affecting
the catalytic activity of the latter, but creating a
scaffold for NELF to bind to this pre-formed RNAPII/
DSIF complex [2,4,7]. Transcription inhibition of
RNAPII is alleviated by the recruitment of chromatin-
specific transcription elongation factor Facilitates
Chromatin Transcription Complex (FACT), together
with the protein kinase Positive Transcription
Elongation Factor b (P-TEFb), which through its
Cyclin-dependent kinase 9  (Cdk9) sub-unit binds to
and phosphorylates the C-terminal repeat domain
(CTD) of RNAPII and DSIF. Upon phosphorylation,
DSIF is converted from a negative to a positive
regulator of transcription, NELF is removed
and RNAPII can proceed to produce full-length
transcripts (Fig. 1) [2,7,20-25].
In Drosophila, promoter-proximal pausing of
RNAPII is present in approximately 10% of genes
in early embryos and 20% of genes in adult S2
cells [26,27], acting as a checkpoint to regulate
transcription [28,29]. Even more so, in human
embryonic stem cells, approximately 75% of protein
coding genes exhibit promoter-proximal pausing of
RNAPII, while only about half of these genes produce
detectable full-length transcripts [30].
Figure 1 Initiation – The transcription factor complex (TF Complex)
binds to the promoter, recruiting RNA Polymerase II (RNAPII) to the
transcription start site (TSS). DSIF, composed of two sub-units (Spt4
and Spt5), then binds to RNAPII and a short RNA strand begins to form.
Pausing – The negative elongation factor complex made up of the sub-
units Nelf-A, Nelf-B, Nelf-C/D, Nelf-E (A, B, C/D, E) is recruited to the TSS
and hypothesised to be stabilised by binding to the TF complex. The
RNA strand formed binds to the RMM domain of Nelf-E, blocking the
elongation process. Elongation – A stimulus brings about recruitment
of P-TEFb (CyclinT and Cdk9), which phosphorylates RNAPII and DSIF
causing the dissociation of the negative elongation factor complex (A,
B, C/D, E) and allowing the extension of the RNA strand, forming a full
transcript.
Biological significance of NELF
The importance of NELF and promoter-proximal
pausing of RNAPII is evident in response to
intracellular and extracellular stimuli e.g. heat shock,
lipopolysaccharide (LPS) and oestrogen [31,37] NELF
localises with RNAPII just downstream of the TSS of
heat shock genes when they are not induced, where
it collaborates with DSIF to establish promoter-
proximal pausing of RNAPII, by associating with
nascent RNAs, 20–60 nucleotide long [6,38,39]. Upon
heat shock, activating factors trigger the release
of RNAPII from its paused state, and there is a
rapid production of full-length transcripts from Heat
Shock Protein (HSP) genes[6,38,39]. A loss of NELF
however, does not affect the rate of heat shock
gene induction but instead delays the time taken for
HSP transcription to decrease down to basal levels
after the heat shock stimulus has ceased, implying
that the presence of NELF somehow facilitates the
dissociation of the transcription factor Heat Shock
Factor (HSF) [40].
NELF activity is also important during
development e.g. in early Drosophila development,
mutant clones lacking NELF-A or NELF-E either
stopped developing before the blastoderm stage
(displaying abnormal nuclear morphology) or during
germ-band retraction (exhibiting head defects and
incomplete dorsal closure). However, it appears that
abnormal NELF has no effect on segmentation genes
(e.g. eve, fushi tarazu, and sloppy paired 1) at the
blastoderm stage [41]. NELF has also been shown to
3play a critical role in the neuronal development of
zebra fish embryos [42-44].
Other contexts involving NELF regulation include
the attenuation of transcription levels of oestrogen-
responsive genes following stimulation [12], the
attenuation of transcription levels of the immediate-
early genes and the transcription factor junB, both
before and after induction [5], as well as the
activation of paused genes involved in the immune
response pathways in Drosophila in response to an
immune challenge [45].
Another set of external and internal stimuli
to which promoter-proximal pausing might be
applicable, but has not been studied so far, is that
involved in reactive oxygen species (ROS) production.
The redox systems involving thioredoxin (TXN) and
glutathione (GSH) are linked to the transcription of
a multitude of genes through their redox effect
on transcription factors [46]. When cells experience
oxidative stress due to excessive ROS, the response
has to be fast and well-co-ordinated and having
primed gene transcripts, as observed for the HSP
genes, appears to be quite plausible.
NELF and cancer
NELF has so far been implicated in some forms of
gastrointestinal and breast cancers. In cancers of
the upper digestive system, both NELF-B and NELF-
E have been found to be overexpressed [47,48]. In
certain breast cancers, NELF-B plays a critical role, as
it binds both BRCA1 and ERα. The NELF complex is
recruited to the ERα-responsive promoters by ERα
through binding with NELF-B.This results in the NELF
complex attenuating ERα-responsive gene activation
and oestrogen-dependent proliferation of breast
cancer cells.Recruitment of NELF to endogenous
ERα-responsive promoters has been shown to be
greatly stimulated upon oestrogen treatment [12].
Thus NELF can be affected by dysregulated BRCA1,
which is a co-repressor of ERα [49-51] and in turn
affect the ERα–oestrogen signalling pathway in
breast cancer development [52-54].
Role of NELF in other
transcription steps
With the emergence of a transcription regulation
model, in which the mRNA processing steps
of capping, splicing, and poly-adenylation are
inter-related and occur co-transcriptionally, rather
than independently and sequentially [55], NELF-
induced promoter-proximal pausing of RNAPII is
thought to provide the conditions for co-ordinating
proper transcript processing [6,12,55-56] in a step
called elongation checkpoint control [57,58]. As
a consequence of the intercalation of mRNA
processing steps, certain proteins may play a role
in different steps as is the case of RNAPII through
changes in its phosphorylation state during capping,
splicing, and poly-adenylation [59].
The involvement of NELF in multiple mRNA
processing steps during transcription is supported
by the report that NELF associates with almost 50%
of the most highly expressed Drosophila genes, but
paused RNAPII is only found is a sub-set of these
genes, indicating that NELF does not only fulfil the
role of repressor of gene expression [60]. This is
achieved through interaction with different factors.
One protein which displays a similar functional-
flexibility to NELF is the nuclear cap binding complex
(CBC), which was originally found to bind to the 5’ cap
structure of maturing RNA and facilitates its export
[61]. However, it also influences the rate of RNA
backbone cleavage steps during splicing [61] and
has an additional role in 3’ end processing [55,62].
Another similar example of a multi-functional factor
is Cleavage and Poly-adenylation Specificity Factor
(CPSF) [55]. NELF appears to interact with certain
factors related to the mRNA 5’ cap, since NELF-
mediated repression of transcription is released
following the recruitment of capping enzyme to the
elongation complex [63].
On the other hand, NELF and CBC appear
to function together in the 3’ end processing
of histone mRNAs, since the knock-down of
either NELF or CBC leads to the accumulation
of a poly-adenylated (poly-A) form of the mRNAs
of replication-dependent histones. This is highly
unusual, as replication-dependent histone mRNAs,
unlike replication-independent histone mRNAs and
other general mRNAs do not normally end in poly-
A tails [64]. In this process, NELF has been shown
to physically associate with histone gene loci and
forms distinct intra-nuclear foci, which often overlap
with Cajal bodies and cleavage bodies. NELF interacts
with CBC, most likely through association with the
histone stem-loop binding protein (SLBP), preventing
the aberrant production of poly-adenylated histone
mRNAs [65].
NELF appears to be also involved in the elongation
phase. In fact, NELF can associate with the oestrogen
receptor as well as other nuclear receptors to
attenuate the level of induction of target genes
indicating that NELF may be actively recruited by
DNA-binding proteins to the elongation complex
[12,66].
NELF and the resulting paused RNAPII have been
implied in the maintenance of histone modifications
typically associated with active transcription, while
preventing the formation of repressive chromatin
both by excluding nucleosomes from the promoter
region and by maintaining patterns of histone
modification that are conducive to activation [67].
NELF interaction with
transcription factors
In addition to the basic complex, both trans-acting
factors and cis-acting elements control transcription
elongation by RNAPII [68,69]. Transcription
elongation factors such as transcription factor IIF
(TFIIF), TFIIS and elongin interact with RNAPII to
prevent its pausing or to reactivate it from a paused
state, while cis-acting elements are mainly located on
nascent RNA transcripts. Some RNA elements cause
RNAPII to pause or arrest without the aid of protein
factors by forming structures that destabilise RNAPII-
DNA-RNA complexes [68,70].
4The activity of transcription factors to recruit
proteins involved in promoter-proximal pausing of
RNAPII is exemplified by the recruitment of P-TEFb
to gene promoters by the transcription factors Myc
and NF-κB [71,72], in addition to the existence
of other mechanisms involving indirect association
with acetylated histones via the chromatin reader,
bromodomain-containing protein 4 (Brd4) [34], or
association with a mediator kinase like cyclin-
dependent protein kinase 8 (Cdk8) [73].
The involvement of transcription factors in the
promoter-proximal pausing of RNAPII by NELF (and
DSIF) is best characterised in the association of
GAGA factor with 39% of the Drosophila gene
promoters that are bound by NELF [60]. Transcription
control of the Drosophila HSP70 gene is one of
the best studied[6,74] . Induction of the HSP70
gene after heat shock, relies on the binding of
the transcription factors, GAGA factor and HSF,
upstream of the core promoter region [75-77]. This
mechanism involves the binding of GAGA factor
before heat shock, which results in the pausing
of primed RNAPII, and then following heat shock,
HSF is induced into binding with the primed HSP70
promoter [36,75,76]. This leads to the recruitment of
P-TEFb to the HSP70 promoter, which removes the
NELF-mediated inhibition [33]. Interestingly, the HSF
activation domain appears to be unable to activate
transcription without the prior action of the GAGA
factor [78].
It has been proposed that during initiation the
GAGA factor acts by recruiting TFIID, (and possibly
the chromatin nuclear remodelling factor (NURF),
and the histone chaperone FACT) and establishing
a nucleosome-free region that allows access of the
transcription machinery to the promoter [79-81].
The resultant promoter-proximal pausing of RNAPII
following GAGA factor initiation is hypothesised
to be a default outcome of the inability of this
transcription factor to overcome the action of NELF,
since it is not able to recruit P-TEFb to the RNAPII
complex [60].
In higher eukaryotes, it might be possible for
transcription factors recognising a similar motif to
fulfil such a role. One possible candidate might
be the E26 Transformation-Specific (ETS) protein
family, which is characterised by a DNA-binding
winged-helix-turn-helix domain that binds to purine-
rich sequences containing a 5’-GGAA/T-3’ core motif
[82,84]. ETS transcription factors act at specific
promoters via protein-protein interactions, and as a
result can function as either activators or repressors
of transcription. Of this family, one of the members
that might be of special interest is E4TF1-60, due
to its ubiquitous presence, action on TATA-less
promoters and unique characteristic of forming
obligate heterodi- or tetramers with E4TF1-53
depending on the presence of single or tandem
ETS consensus motifs within promoters [82-87].
One way this transcription factor obtains promoter
specificity is through the positioning of single
E4TF1-binding sites adjacent to the binding sites
of other transcription factors such as Sp1 [88].
Post-translational modifications further modulate
the transcriptional activity by affecting stability
or binding strength (Baron, 2014b). Thus, such a
transcription factor or the complexes it forms could
either recruit or stabilise the NELF complex through
interaction with one of the sub-units, enabling
promoter-proximal pausing of a response-specific
group of genes.
Conclusion
The available data suggests that the NELF complex
is crucial in the priming of genes that respond to
various stimuli through promoter-proximal pausing
of RNAPII, which thus allows for a rapid response to
changes in cellular conditions such as in the case of
heat shock. This opens a whole new perspective into
different groups of response genes and of particular
interest is the oxidative-stress context since this
might help provide insight into the response
of cancers to increased intracellular ROS levels.
However, as part of the transcription regulation
model, NELF, like other transcription-related factors
plays multiple roles and participates in multiple
steps throughout the process of transcription.
Each sub-unit has unique protein domains which
can fulfil different functions in distinct stages of
transcription. Moreover, NELF interacts with other
factors, to specifically target such processes. As
shown by GAGA factor in Drosophila, ubiquitous
mammalian transcription factors such as ETS family
transcription factors might be involved in the
recruiting or stabilisation of the NELF complex during
transcription suppression.
Perspectives
Multiple questions arise from the current knowledge
on the NELF complex: Does the NELF-E RRM encode
an important function other than RNA binding? How
is the NELF complex recruited to the TSS of specific
genes? To what extent do transcription factors
control the initial association of the NELF complex
with the elongation complex? Are transcription
factors involved in promoter clearance of NELF in
response to context-dependent signals/stimuli? Can
oxidative stress lead to the release of NELF and
initiation of transcription activation in a subset of
genes? Is NELF regulation achieved by the association
of one or more of the NELF sub-units with trans-
acting factors or cis-acting RNA elements? With more
focus on the interactions, domains and activities of
the separate NELF sub-units, a better understanding
of the roles of these proteins in the transcription
process can be achieved. This has significance both
academically and clinically as transcription control
can be a therapeutic target for various cancers.
 
References
1. Narita T, Yamaguchi Y, Yano K, Sugimoto S, Chanarat S,  et al.
(2003). Human transcription elongation factor NELF: identification
of novel subunits and reconstitution of the functionally active
complex. Mol Cell Biol, 23(6): 1863-1873.
2. Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A,  et al. (1999).
NELF, a multisubunit complex containing RD, cooperates with DSIF
to repress RNA polymerase II elongation. Cell, 97(1): 41-51.
53. Yamaguchi Y, Filipovska J, Yano K, Furuya A, Inukai N,  et al. (2001).
Stimulation of RNA polymerase II elongation by hepatitis delta
antigen. Science, 293(5527): 124-127.
4. Yamaguchi Y, Inukai N, Narita T, Wada T, Handa H (2002).
Evidence that negative elongation factor represses transcription
elongation through binding to a DRB sensitivity-inducing factor/
RNA polymerase II complex and RNA. Mol Cell Biol, 22(9):
2918-2927.
5. Aida M, Chen Y, Nakajima K, Yamaguchi Y, Wada T,  et al. (2006).
Transcriptional pausing caused by NELF plays a dual role in
regulating immediate-early expression of the junB gene. Mol Cell
Biol, 26(16): 6094-6104.
6. Wu CH, Yamaguchi Y, Benjamin LR, Horvat-Gordon M, Washinsky J,
et al. (2003). NELF and DSIF cause promoter proximal pausing on
the hsp70 promoter in Drosophila. Genes Dev, 17(11): 1402-1414.
7. Yamaguchi Y, Wada T, Watanabe D, Takagi T, Hasegawa J,  et
al. (1999). Structure and function of the human transcription
elongation factor DSIF. J Biol Chem, 274(12): 8085-8092.
8. Wright TJ, Costa JL, Naranjo C, Francis-West P, Altherr MR
(1999). Comparative analysis of a novel gene from the Wolf-
Hirschhorn/Pitt-Rogers-Danks syndrome critical region. Genomics,
59(2): 203-212.
9. Zollino M, Murdolo M, Marangi G, Pecile V, Galasso C,  et al.
(2008). On the nosology and pathogenesis of Wolf-Hirschhorn
syndrome: genotype-phenotype correlation analysis of 80 patients
and literature review. Am J Med Genet C Semin Med Genet, 148C(4):
257-269.
10. Kerzendorfer C, Hannes F, Colnaghi R, Abramowicz I, Carpenter
G,  et al. (2012). Characterizing the functional consequences of
haploinsufficiency of NELF-A (WHSC2) and SLBP identifies novel
cellular phenotypes in Wolf-Hirschhorn syndrome. Hum Mol Genet,
21(10): 2181-2193.
11. Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS,  et al. (2001). BRCA1-
induced large-scale chromatin unfolding and allele-specific effects
of cancer-predisposing mutations. J Cell Biol, 155(6): 911-921.
12. Aiyar SE, Sun JL, Blair AL, Moskaluk CA, Lu YZ,  et al. (2004).
Attenuation of estrogen receptor alpha-mediated transcription
through estrogen-stimulated recruitment of a negative elongation
factor. Genes Dev, 18(17): 2134-2146.
13. Zhu J, Song S, Jiang Z, Yan J, Lu Q,  et al. (2004). Characterization of
COBRA1 in human breast cancer cell lines using a new polyclonal
antibody against COBRA1. IUBMB Life, 56(3): 161-166.
14. Sun J, Watkins G, Blair AL, Moskaluk C, Ghosh S,  et al. (2008).
Deregulation of cofactor of BRCA1 expression in breast cancer
cells. J Cell Biochem, 103(6): 1798-1807.
15. Amleh A, Nair SJ, Sun J, Sutherland A, Hasty P,  et al. (2009). Mouse
cofactor of BRCA1 (Cobra1) is required for early embryogenesis.
PLoS One, 4(4): e5034.
16. Kim YJ, Baker BS (1993). Isolation of RRM-type RNA-binding
protein genes and the analysis of their relatedness by using a
numerical approach. Mol Cell Biol, 13(1): 174-183.
17. Mattaj IW (1993). RNA recognition: a family matter? Cell, 73(5):
837-840.
18. Steinmetz EJ, Warren CL, Kuehner JN, Panbehi B, Ansari AZ,  et al.
(2006). Genome-wide distribution of yeast RNA polymerase II and
its control by Sen1 helicase. Mol Cell, 24(5): 735-746.
19. Wada T, Takagi T, Yamaguchi Y, Ferdous A, Imai T,  et al. (1998).
DSIF, a novel transcription elongation factor that regulates RNA
polymerase II processivity, is composed of human Spt4 and Spt5
homologs. Genes Dev, 12(3): 343-356.
20. Bourgeois CF, Kim YK, Churcher MJ, West MJ, Karn J (2002). Spt5
cooperates with human immunodeficiency virus type 1 Tat by
preventing premature RNA release at terminator sequences. Mol
Cell Biol, 22(4): 1079-1093.
21. Ping YH, Rana TM (2001). DSIF and NELF interact with RNA
polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-
mediated phosphorylation of RNA polymerase II and DSIF during
transcription elongation. J Biol Chem, 276(16): 12951-12958.
22. Price DH (2000). P-TEFb, a cyclin-dependent kinase controlling
elongation by RNA polymerase II. Mol Cell Biol, 20(8): 2629-2634.
23. Renner DB, Yamaguchi Y, Wada T, Handa H, Price DH (2001). A
highly purified RNA polymerase II elongation control system. J Biol
Chem, 276(45): 42601-42609.
24. Wada T, Takagi T, Yamaguchi Y, Watanabe D, Handa H (1998).
Evidence that P-TEFb alleviates the negative effect of DSIF on RNA
polymerase II-dependent transcription in vitro. EMBO J, 17(24):
7395-7403.
25. Wada T, Orphanides G, Hasegawa J, Kim DK, Shima D,  et al. (2000).
FACT relieves DSIF/NELF-mediated inhibition of transcriptional
elongation and reveals functional differences between P-TEFb and
TFIIH. Mol Cell, 5(6): 1067-1072.
26. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS,  et al. (2007).
RNA polymerase is poised for activation across the genome. Nat
Genet, 39(12): 1507-1511.
27. Zeitlinger J, Stark A, Kellis M, Hong JW, Nechaev S,  et al. (2007).
RNA polymerase stalling at developmental control genes in the
Drosophila melanogaster embryo. Nat Genet, 39(12): 1512-1516.
28. Nechaev S, Fargo DC, dos Santos G, Liu L, Gao Y,  et al. (2010). Global
analysis of short RNAs reveals widespread promoter-proximal
stalling and arrest of Pol II in Drosophila. Science, 327(5963):
335-338.
29. Core LJ, Waterfall JJ, Gilchrist DA, Fargo DC, Kwak H,  et al. (2012).
Defining the status of RNA polymerase at promoters. Cell Rep, 2(4):
1025-1035.
30. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA (2007). A
chromatin landmark and transcription initiation at most promoters
in human cells. Cell, 130(1): 77-88.
31. Andrulis ED, Guzmán E, Döring P, Werner J, Lis JT (2000). High-
resolution localization of Drosophila Spt5 and Spt6 at heat shock
genes in vivo: roles in promoter proximal pausing and transcription
elongation. Genes Dev, 14(20): 2635-2649.
32. Kaplan CD, Morris JR, Wu C, Winston F (2000). Spt5 and spt6 are
associated with active transcription and have characteristics of
general elongation factors in D. melanogaster. Genes Dev, 14(20):
2623-2634.
33. Lis JT, Mason P, Peng J, Price DH, Werner J (2000). P-TEFb kinase
recruitment and function at heat shock loci. Genes Dev, 14(7):
792-803.
34. Hargreaves DC, Horng T, Medzhitov R (2009). Control of inducible
gene expression by signal-dependent transcriptional elongation.
Cell, 138(1): 129-145.
35. Kininis M, Isaacs GD, Core LJ, Hah N, Kraus WL (2009).
Postrecruitment regulation of RNA polymerase II directs rapid
signaling responses at the promoters of estrogen target genes.
Mol Cell Biol, 29(5): 1123-1133.
36. Boehm AK, Saunders A, Werner J, Lis JT (2003). Transcription
factor and polymerase recruitment, modification, and movement
on dhsp70 in vivo in the minutes following heat shock. Mol Cell Biol,
23(21): 7628-7637.
37. Adelman K, Kennedy MA, Nechaev S, Gilchrist DA, Muse GW,  et
al. (2009). Immediate mediators of the inflammatory response are
poised for gene activation through RNA polymerase II stalling. Proc
Natl Acad Sci U S A, 106(43): 18207-18212.
38. Rougvie AE, Lis JT (1988). The RNA polymerase II molecule at
the 5' end of the uninduced hsp70 gene of D. melanogaster is
transcriptionally engaged. Cell, 54(6): 795-804.
39. Rasmussen EB, Lis JT (1993). In vivo transcriptional pausing and cap
formation on three Drosophila heat shock genes. Proc Natl Acad
Sci U S A, 90(17): 7923-7927.
40. Ghosh SK, Missra A, Gilmour DS (2011). Negative elongation factor
accelerates the rate at which heat shock genes are shut off by
facilitating dissociation of heat shock factor. Mol Cell Biol, 31(20):
4232-4243.
41. Wang X, Hang S, Prazak L, Gergen JP (2010). NELF potentiates
gene transcription in the Drosophila embryo. PLoS One, 5(7):
e11498.
42. Guo S, Yamaguchi Y, Schilbach S, Wada T, Lee J,  et al. (2000).
A regulator of transcriptional elongation controls vertebrate
neuronal development. Nature, 408(6810): 366-369.
43. Yamaguchi Y, Narita T, Inukai N, Wada T, Handa H (2001). SPT genes:
key players in the regulation of transcription, chromatin structure
and other cellular processes. J Biochem, 129(2): 185-191.
44. Zorio DA, Bentley DL (2001). Transcription elongation: the 'Foggy'
is liftingellipsis. Curr Biol, 11(4): R144-146.
45. Gilchrist DA, Fromm G, dos Santos G, Pham LN, McDaniel IE,  et al.
(2012). Regulating the regulators: the pervasive effects of Pol II
pausing on stimulus-responsive gene networks. Genes Dev, 26(9):
933-944.
46. Baron B (2014). The role of redox-sensitive cysteines in multi sub-
unit transcription factors. Biohelikon: Cell Biology, 2: a17.
47. McChesney PA, Aiyar SE, Lee OJ, Zaika A, Moskaluk C,  et al. (2006).
Cofactor of BRCA1: a novel transcription factor regulator in upper
gastrointestinal adenocarcinomas. Cancer Res, 66(3): 1346-1353.
48. Midorikawa Y, Tsutsumi S, Taniguchi H, Ishii M, Kobune Y,  et al.
(2002). Identification of genes associated with dedifferentiation of
hepatocellular carcinoma with expression profiling analysis. Jpn J
Cancer Res, 93(6): 636-643.
49. Fan S, Wang J, Yuan R, Ma Y, Meng Q,  et al. (1999). BRCA1
inhibition of estrogen receptor signaling in transfected cells.
Science, 284(5418): 1354-1356.
50. Fan S, Ma YX, Wang C, Yuan RQ, Meng Q,  et al. (2001). Role of
direct interaction in BRCA1 inhibition of estrogen receptor activity.
Oncogene, 20(1): 77-87.
51. Zheng L, Annab LA, Afshari CA, Lee WH, Boyer TG (2001). BRCA1
mediates ligand-independent transcriptional repression of the
estrogen receptor. Proc Natl Acad Sci U S A, 98(17): 9587-9592.
52. Persson I (2000). Estrogens in the causation of breast,
endometrial and ovarian cancers - evidence and hypotheses
6from epidemiological findings. J Steroid Biochem Mol Biol, 74(5):
357-364.
53. Foster JS, Henley DC, Ahamed S, Wimalasena J (2001). Estrogens
and cell-cycle regulation in breast cancer. Trends Endocrinol Metab,
12(7): 320-327.
54. Ali S, Coombes RC (2002). Endocrine-responsive breast cancer and
strategies for combating resistance. Nat Rev Cancer, 2(2): 101-112.
55. Proudfoot NJ, Furger A, Dye MJ (2002). Integrating mRNA
processing with transcription. Cell, 108(4): 501-512.
56. Fujinaga K,  et al. (2004). Dynamics of human immunodeficiency
virus transcription: P-TEFb phosphorylates RD and dissociates
negative effectors from the transactivation response element. Mol
Cell Biol, 24: 787-795.
57. Mandal SS, Chu C, Wada T, Handa H, Shatkin AJ,  et al. (2004).
Functional interactions of RNA-capping enzyme with factors that
positively and negatively regulate promoter escape by RNA
polymerase II. Proc Natl Acad Sci U S A, 101(20): 7572-7577.
58. Pei Y, Schwer B, Shuman S (2003). Interactions between fission
yeast Cdk9, its cyclin partner Pch1, and mRNA capping enzyme
Pct1 suggest an elongation checkpoint for mRNA quality control.
J Biol Chem, 278(9): 7180-7188.
59. Hirose Y, Manley JL (2000). RNA polymerase II and the integration
of nuclear events. Genes Dev, 14(12): 1415-1429.
60. Lee C, Li X, Hechmer A, Eisen M, Biggin MD,  et al. (2008). NELF
and GAGA factor are linked to promoter-proximal pausing at many
genes in Drosophila. Mol Cell Biol, 28(10): 3290-3300.
61. Izaurralde E, Lewis J, McGuigan C, Jankowska M, Darzynkiewicz E,
et al. (1994). A nuclear cap binding protein complex involved in pre-
mRNA splicing. Cell, 78(4): 657-668.
62. Flaherty SM, Fortes P, Izaurralde E, Mattaj IW, Gilmartin GM (1997).
Participation of the nuclear cap binding complex in pre-mRNA 3'
processing. Proc Natl Acad Sci U S A, 94(22): 11893-11898.
63. Mandal SS, Chu C, Wada T, Handa H, Shatkin AJ,  et al. (2004).
Functional interactions of RNA-capping enzyme with factors that
positively and negatively regulate promoter escape by RNA
polymerase II. Proc Natl Acad Sci U S A, 101(20): 7572-7577.
64. Marzluff WF (2005). Metazoan replication-dependent histone
mRNAs: a distinct set of RNA polymerase II transcripts. Curr Opin
Cell Biol, 17(3): 274-280.
65. Narita T, Yung TM, Yamamoto J, Tsuboi Y, Tanabe H,  et al. (2007).
NELF interacts with CBC and participates in 3' end processing of
replication-dependent histone mRNAs. Mol Cell, 26(3): 349-365.
66. Sun J, Blair AL, Aiyar SE, Li R (2007). Cofactor of BRCA1 modulates
androgen-dependent transcription and alternative splicing. J
Steroid Biochem Mol Biol, 107(3-5): 131-9.
67. Sun J, Li R (2010). Human negative elongation factor activates
transcription and regulates alternative transcription initiation. J
Biol Chem, 285(9): 6443-6452.
68. Uptain SM, Kane CM, Chamberlin MJ (1997). Basic mechanisms
of transcript elongation and its regulation. Annu Rev Biochem, 66:
117-172.
69. Conaway JW, Shilatifard A, Dvir A, Conaway RC (2000). Control
of elongation by RNA polymerase II. Trends Biochem Sci, 25(8):
375-380.
70. Nudler E (1999). Transcription elongation: structural basis and
mechanisms. J Mol Biol, 288(1): 1-12.
71. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S,  et al. (2010). c-Myc
regulates transcriptional pause release. Cell, 141(3): 432-445.
72. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin
BM (2001). NF-kappaB binds P-TEFb to stimulate transcriptional
elongation by RNA polymerase II. Mol Cell, 8(2): 327-337.
73. Donner AJ, Ebmeier CC, Taatjes DJ, Espinosa JM (2010). CDK8 is a
positive regulator of transcriptional elongation within the serum
response network. Nat Struct Mol Biol, 17(2): 194-201.
74. Wu CH, Lee C, Fan R, Smith MJ, Yamaguchi Y,  et al. (2005).
Molecular characterization of Drosophila NELF. Nucleic Acids Res,
33(4): 1269-1279.
75. Lee H, Kraus KW, Wolfner MF, Lis JT (1992). DNA sequence
requirements for generating paused polymerase at the start of
hsp70. Genes Dev, 6(2): 284-295.
76. Shopland LS, Hirayoshi K, Fernandes M, Lis JT (1995). HSF access
to heat shock elements in vivo depends critically on promoter
architecture defined by GAGA factor, TFIID, and RNA polymerase II
binding sites. Genes Dev, 9(22): 2756-2769.
77. Lis JT, Wu C. (1994). Transcriptional regulation of heat shock genes
Conaway RC and Conaway JW (ed.), Transcription: mechanisms and
regulation. Raven Press, Ltd., New York, NY, p. 459-475.
78. Wang YV, Tang H, Gilmour DS (2005). Identification in vivo
of different rate-limiting steps associated with transcriptional
activators in the presence and absence of a GAGA element. Mol Cell
Biol, 25(9): 3543-3552.
79. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B,  et al. (2003).
A protein interaction map of Drosophila melanogaster. Science,
302(5651): 1727-1736.
80. Nakayama T, Nishioka K, Dong YX, Shimojima T, Hirose S
(2007). Drosophila GAGA factor directs histone H3.3 replacement
that prevents the heterochromatin spreading. Genes Dev, 21(5):
552-561.
81. Xiao H, Sandaltzopoulos R, Wang HM, Hamiche A, Ranallo R,  et
al. (2001). Dual functions of largest NURF subunit NURF301 in
nucleosome sliding and transcription factor interactions. Mol Cell,
8(3): 531-543.
82. Sharrocks AD, Brown AL, Ling Y, Yates PR (1997). The ETS-
domain transcription factor family. Int J Biochem Cell Biol, 29(12):
1371-1387.
83. Sharrocks AD (2001). The ETS-domain transcription factor family.
Nat Rev Mol Cell Biol, 2(11): 827-837.
84. Wasylyk B, Hahn SL, Giovane A (1993). The Ets family of
transcription factors. Eur J Biochem, 211(1-2): 7-18.
85. Watanabe H, Wada T, Handa H (1990). Transcription factor E4TF1
contains two subunits with different functions. EMBO J, 9(3):
841-847.
86. Thompson CC, Brown TA, McKnight SL (1991). Convergence of Ets-
and notch-related structural motifs in a heteromeric DNA binding
complex. Science, 253(5021): 762-768.
87. Oikawa T, Yamada T (2003). Molecular biology of the Ets family of
transcription factors. Gene, 303: 11-34.
88. Valouev A, Johnson DS, Sundquist A, Medina C, Anton E,  et al.
(2008). Genome-wide analysis of transcription factor binding sites
based on ChIP-Seq data. Nat Methods, 5(9): 829-834.
89. Baron B (2014). The lysine multi-switch: the impact of lysine
methylation on transcription factor properties. Biohelikon: Cell
Biology, 2:a13.
